heXembio
Rejuvenating human blood cells for improved healthspan.
* Data source: Crunchbase
- Founded
- 2024
- Employees*
- 2-10
- Funding to Date*
- $6,031,000
- Website
- www.hexemb.io
“This is a trillion-dollar market because we're talking about the rejuvenation of almost any adult and the potential to treat or prevent 20 diseases. We are proud to push the boundaries of possibilities in the human longevity space.”
In the United States, people over the age of 55 account for over 55% of healthcare spending—about $2.5 trillion annually.
Rejuvenating human blood cells for improved healthspan.
More Companies
